TOLERABILITY AND STEADY-STATE PHARMACOKINETICS OF FELBAMATE FOLLOWINGMONO-THERAPY OVER THE ORAL DOSE RANGE OF 3600 TO 6000 MG DAY IN SUBJECTS WITH EPILEPSY/
R. Sachdeo et al., TOLERABILITY AND STEADY-STATE PHARMACOKINETICS OF FELBAMATE FOLLOWINGMONO-THERAPY OVER THE ORAL DOSE RANGE OF 3600 TO 6000 MG DAY IN SUBJECTS WITH EPILEPSY/, Neurology, 44(4), 1994, pp. 10000296-10000296